Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bull Soc Pathol Exot ; 95(3): 144-7, 2002 Aug.
Artículo en Francés | MEDLINE | ID: mdl-12404855

RESUMEN

The standardisation of serotherapy is necessary in Africa mainly because of the frequency of envenomations and the lack of alternative treatments. Comparative titrations of FAV-Afrique (Aventis Pasteur), Polyvalent serum (Serum Institute of India = SII) and Polyvalent antivenin (South African Vaccine Fabricants Ltd = SAIMR) were carried out on venoms of Echis ocellatus from Cameroun, E. ocellatus from Mali, E. leucogaster and Naja melanoleuca. The 50% protective doses (ED50) of the antivenoms were given according either to i) the in vitro method which consists of inoculating 5 batches of 5 mice with a mixture containing 3 DL50 of venom and increasing volumes of antivenom incubated for 30 mn at 37 degrees C and ii) the in vivo method which consists of successive administration of venom and then antivenom after a 30 to 60 mn interval. The three antivenoms showed a similar efficacy against all the Echis venoms. Interestingly, the SAIMR proved to be effective against the venom of E. leucogaster and E. ocellatus although no venom of Echis was used to immunise horses during the preparation of antivenom. Conversely, this paraspecificity did not exist with the Naja melanoleuca venom against which FAV Afrique showed a higher efficacy. The electrophoresis pattern of FAV-Afrique performed on acetate gel strips showed only one protein fraction (76 g.l-1), whereas both the SII and SAIMR antivenoms showed four fractions whose protein concentrations was respectively 64 g.l-1 and 145 g.l-1.


Asunto(s)
Antivenenos/química , Antivenenos/uso terapéutico , Venenos Elapídicos/toxicidad , Mordeduras de Serpientes/terapia , Volumetría/métodos , Venenos de Víboras/toxicidad , África del Sur del Sahara , Animales , Camerún , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Electroforesis en Acetato de Celulosa , Dosificación Letal Mediana , Malí , Ratones , Equivalencia Terapéutica , Factores de Tiempo
2.
Arch Inst Pasteur Madagascar ; 68(1-2): 44-7, 2002.
Artículo en Francés | MEDLINE | ID: mdl-12643091

RESUMEN

In 1991, the National Tuberculosis control Program (NTP) of Madagascar adopted the short treatment course and the Directly Observed Treatment Strategy (DOTS), according to the recommendations of the OMS/UICTMR. Development of M. tuberculosis primary resistance to the four antituberculosis drugs (streptomycin [S], rifampicine [R], isoniazid [H], ethambutol [E]) is an indicator of the NTP efficiency. We report results from a five-year survey among patients with new smear positive pulmonary tuberculosis. Acquired resistance is assessed among recurrent cases. During the first survey, carried out in 1994-1995 in four large cities, multidrug resistance (MDR) rate to the major antituberculosis drug H and R was low, 0.25% for primary MDR and 5% for acquired MDR. No primary MDR was found in Antananarivo; on the other hand, acquired resistance rate was the highest there (22%). Because of logistical reasons, the second survey (1999-2000) was only carried out in the capital, Antananarivo. Results obtained among 789 new patients with smear positive pulmonary tuberculosis and 79 recurrents cases in 9 diagnostic centres showed low primary and acquired resistance of 11.1% to any drug. Primary resistance to one drug was 10.6%, mainly due to streptomycin 8.5%. MDR rates are comparable with those observed in 1994-1995: 0.1% for primary MDR and 4% for acquired MDR. These results show that ten years after the new NTP implementation, only a few MDR strains are circulating in Antananarivo, which suggests that NTP has been effective.


Asunto(s)
Antituberculosos/uso terapéutico , Farmacorresistencia Bacteriana Múltiple/genética , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/genética , Tuberculosis Resistente a Múltiples Medicamentos/epidemiología , Tuberculosis Resistente a Múltiples Medicamentos/microbiología , Tuberculosis Pulmonar/epidemiología , Tuberculosis Pulmonar/microbiología , Salud Urbana/estadística & datos numéricos , Antibióticos Antituberculosos/uso terapéutico , Terapia por Observación Directa , Etambutol/uso terapéutico , Femenino , Humanos , Isoniazida/uso terapéutico , Madagascar/epidemiología , Masculino , Pruebas de Sensibilidad Microbiana , Epidemiología Molecular , Programas Nacionales de Salud , Vigilancia de la Población , Estudios Prospectivos , Recurrencia , Rifampin/uso terapéutico , Estreptomicina/uso terapéutico , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Pulmonar/tratamiento farmacológico
3.
Fitoterapia ; 72(1): 22-9, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11163936

RESUMEN

The decoction of the rhizome of Cyperus articulatus is empirically used in several African countries in the treatment of a wide variety of human diseases. Studies were conducted in mice in order to determine scientifically the pharmacological properties of this medicinal herb. At the same time, the qualitative chemical characterisation of the total extract showed that C. articulatus contains flavonoids, saponins, tannins, terpenes and sugars. The total extract of the rhizome of C. articulatus does not appear to possess either anaesthetic or paralysing effects. In contrast, spontaneous motor activity is significantly reduced by the extract. However, when compared to diazepam, C. articulatus does not seem to have muscle relaxant effects. When associated with sodium thiopental or diazepam, the total extract facilitates sleep induction, and increases the total sleep time without any concomitant analgesic effect. These observations suggest that the rhizome of C. articulatus has pharmacological properties similar to those of sedatives. The sedative actions probably explain at least part of the therapeutic efficiency claimed for this plant in traditional medicine.


Asunto(s)
Hipnóticos y Sedantes/farmacología , Actividad Motora/efectos de los fármacos , Extractos Vegetales/farmacología , Plantas Medicinales , Sueño/efectos de los fármacos , Animales , Femenino , Humanos , Masculino , Medicinas Tradicionales Africanas , Ratones , Relajación Muscular/efectos de los fármacos , Dolor/prevención & control , Raíces de Plantas/química
4.
Bull Soc Pathol Exot ; 90(4): 282-5, 1997.
Artículo en Francés | MEDLINE | ID: mdl-9479470

RESUMEN

Dendroaspis jamesoni (Elapidae) and Echis oceliatus (Viperidae) are responsible for most of severe evenomation in Cameroon. Toxicity of venoms of these two species has been measured using mice according to the method of Spearman & Kàrber. The effect on experimental envenomation of various drugs (atropine, promethazine, neostigmine, hydrocortisone, pentosane sulfuric polyester, heparin, tranexamic acid and aminocaproic acid) and plant extracts (Schumanniophyton magnificum, Bidens pilosa, Securidaca longepedunculata and Garcinia lucida) has been observed associated or not with the antivenom lpser Afrique (SAV). The venom of D. jamesoni contains neurotoxins agonizing and antagonising acetylcholine. The toxicity of the venom did not depend on the route of injection. Atropine, promethazine, neostigmine and hydrocortisone protected animals against a venom dose up to 2 LD50. Moreover, atropine and promethazine potentiated the SAV. Similar results have been obtained with extracts from S. magnificum and B. pilosa. The venom of E. ocellatus induces haemorrhage and necrosis. The toxicity increased by 3-fold when the venom was injected through intravenous or intraperitoneal route, compared to intramuscular route. Pentosane sulfuric polyester and tranexamic acid protected mice against doses up to 3 LD50. Pentosane sulfuric polyester, hydrocortisone, heparin and aminocaproic acid increased the SAV protective titre by 50%. However, tried plant extracts weakly antagonised the venom and did not potentiate the SAV.


Asunto(s)
Antivenenos/efectos de los fármacos , Antivenenos/farmacología , Venenos Elapídicos/antagonistas & inhibidores , Venenos Elapídicos/farmacología , Extractos Vegetales/farmacología , Venenos de Víboras/antagonistas & inhibidores , Venenos de Víboras/farmacología , Aminocaproatos/farmacología , Animales , Atropina/farmacología , Bioensayo , Evaluación Preclínica de Medicamentos , Sinergismo Farmacológico , Heparina/farmacología , Hidrocortisona/farmacología , Ratones , Neostigmina/farmacología , Poliéster Pentosan Sulfúrico/farmacología , Prometazina/farmacología , Ácido Tranexámico/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...